USFDA APPROVED CELLULAR AND GENE THERAPY PRODUCTS
● ABECMA (idecabtagene vicleucel) - Celgene Corporation, a Bristol-Myers Squibb Company ● ALLOCORD (HPC, Cord Blood) - SSM Cardinal Glennon Children’s Medical Center
● BREYANZI - Juno Therapeutics, Inc., a BristolMyers Squibb Company
● CLEVECORD (HPC Cord Blood) - Cleveland Cord Blood Center
● Ducord, HPC Cord Blood - Duke University School of Medicine
● GINTUIT (Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen) - Organogenesis Incorporated
● HEMACORD (HPC, cord blood) - New York Blood Center
● HPC, Cord Blood - Clinimmune Labs, University of Colorado Cord Blood Bank
● HPC, Cord Blood - MD Anderson Cord Blood Bank - MD Anderson Cord Blood Bank
● HPC, Cord Blood – Bloodworks - Bloodworks
● HPC, Cord Blood – LifeSouth - LifeSouth Community Blood Centers, Inc.
● IMLYGIC (talimogene laherparepvec) - BioVex, Inc., a subsidiary of Amgen Inc.
● KYMRIAH (tisagenlecleucel) - Novartis Pharmaceuticals Corporation
● LAVIV (Azficel-T) - Fibrocall Technologies ● LUXTURNA - Spark Therapeutics, Inc.
● MACI (Autologous Cultured Chondrocytes on a Porcine Collagen Membrane) - Vericel Corp. ● PROVENGE (sipuleucel-T) - Dendreon Corp. ● RYPLAZIM (plasminogen, human-tvmh) - Prometic Biotherapeutics Inc.
● STRATAGRAFT - Stratatech Corporation ● TECARTUS (brexucabtagene autoleucel) - Kite Pharma, Inc.
● YESCARTA (axicabtagene ciloleucel) - Kite Pharma, Incorporated
● ZOLGENSMA (onasemnogene abeparvovec-xioi) - AveXis, Inc.